Research Progress on the Role of Thioredoxin-Interacting Protein in Polycystic Ovary Syndrome

doi:10.12280/gjfckx.20220603

Abstract

Abstract:

Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disease commonly in women of reproductive age, characterized by irregular menstruation, hyperandrogenemia and polycystic ovary changes, often manifested as obesity, infertility and insulin resistance. Thioredoxin-interacting protein (TXNIP) is a multifunctional regulator that is not only involved in the regulation of insulin secretion and glucose metabolism, but also closely related to oxidative stress, inflammatory factors and mood disorders. Studies have shown that TXNIP levels are significantly increased in PCOS patients, suggesting that TXNIP may be involved in the development of PCOS and its complications. In recent years, some in vivo and ex vivo studies have attempted to use herbal extracts and western drugs to inhibit TXNIP expression, and the discovery of TXNIP-specific inhibitors makes it a promising and effective target to inhibit the process of PCOS. This article reviews the role of TXNIP in PCOS, in order to provide new ideas and directions for the in-depth study of PCOS pathogenesis and its clinical diagnosis and treatment.

Key words: Thioredoxin-interacting protein, Polycystic ovary syndrome, Insulin resistance, Inflammatory, Metabolism

YE Sha, HUANG Ye-pei, MA Lin, BAO Xiao-yan, YANG Ru, DENG Miao, HUANG Jian. Research Progress on the Role of Thioredoxin-Interacting Protein in Polycystic Ovary Syndrome[J]. Journal of International Obstetrics and Gynecology, 2022, 49(6): 708-712.

Figures/Tables 1

References 38

[1]	薛诗瑶, 杨刚毅. 多囊卵巢综合征的诊治进展[J]. 中华内分泌代谢杂志, 2020, 36(1):88-92. doi: 10.3760/cma.j.issn.1000-6699.2020.01.013. doi: 10.3760/cma.j.issn.1000-6699.2020.01.013
[2]	Qayyum N, Haseeb M, Kim MS, et al. Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook[J]. Int J Mol Sci, 2021, 22(5):2754. doi: 10.3390/ijms22052754. doi: 10.3390/ijms22052754
[3]	Wu J, Wu Y, Zhang X, et al. Elevated serum thioredoxin-interacting protein in women with polycystic ovary syndrome is associated with insulin resistance[J]. Clin Endocrinol (Oxf), 2014, 80(4):538-544. doi: 10.1111/cen.12192. doi: 10.1111/cen.12192
[4]	Domingues A, Jolibois J, Marquet de Rougé P, et al. The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target[J]. Int J Mol Sci, 2021, 22(4):1693. doi: 10.3390/ijms22041693. doi: 10.3390/ijms22041693
[5]	Mohamed IN, Li L, Ismael S, et al. Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response[J]. World J Diabetes, 2021, 12(12):1979-1999. doi: 10.4239/wjd.v12.i12.1979. doi: 10.4239/wjd.v12.i12.1979 pmid: 35047114
[6]	扶涛, 张学云, 骆严. 硫氧还蛋白互作蛋白研究进展[J]. 生命的化学, 2019, 39(3):438-445. doi: 10.13488/j.smhx.20180134. doi: 10.13488/j.smhx.20180134
[7]	Suzuki S, Yokoyama A, Noro E, et al. Expression and pathophysiological significance of carbohydrate response element binding protein (ChREBP) in the renal tubules of diabetic kidney[J]. Endocr J, 2020, 67(3):335-345. doi: 10.1507/endocrj.EJ19-0133. doi: 10.1507/endocrj.EJ19-0133 pmid: 31813922
[8]	Parikh H, Carlsson E, Chutkow WA, et al. TXNIP regulates peripheral glucose metabolism in humans[J]. PLoS Med, 2007, 4(5):e158. doi: 10.1371/journal.pmed.0040158. doi: 10.1371/journal.pmed.0040158 pmid: 17472435
[9]	Shorakae S, Ranasinha S, Abell S, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS[J]. Clin Endocrinol (Oxf), 2018, 89(5):628-633. doi: 10.1111/cen.13808. doi: 10.1111/cen.13808
[10]	Shalev A. Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell[J]. Mol Endocrinol, 2014, 28(8):1211-1220. doi: 10.1210/me.2014-1095. doi: 10.1210/me.2014-1095 pmid: 24911120
[11]	Chutkow WA, Lee RT. Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability[J]. J Biol Chem, 2011, 286(33):29139-29145. doi: 10.1074/jbc.M111.267666. doi: 10.1074/jbc.M111.267666 pmid: 21705327
[12]	孙雅南, 潘佳秋, 张丽丽, 等. 硫氧还蛋白互作蛋白与胰岛功能及胰岛素抵抗的相关性[J]. 湖北民族学院学报(医学版), 2019, 36(1):28-30,34.
[13]	Lian D, Yuan H, Yin X, et al. Puerarin inhibits hyperglycemia-induced inter-endothelial junction through suppressing endothelial Nlrp3 inflammasome activation via ROS-dependent oxidative pathway[J]. Phytomedicine, 2019, 55:310-319. doi: 10.1016/j.phymed.2018.10.013. doi: S0944-7113(18)30535-X pmid: 30385134
[14]	Ke B, Shen W, Fang X, et al. The NLPR3 inflammasome and obesity-related kidney disease[J]. J Cell Mol Med, 2018, 22(1):16-24. doi: 10.1111/jcmm.13333. doi: 10.1111/jcmm.13333 pmid: 28857469
[15]	Kelly CC, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome[J]. J Clin Endocrinol Metab, 2001, 86(6):2453-2455. doi: 10.1210/jcem.86.6.7580. doi: 10.1210/jcem.86.6.7580
[16]	Moulana M. Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome[J]. Life Sci, 2019, 220:44-49. doi: 10.1016/j.lfs.2019.01.048. doi: S0024-3205(19)30061-X pmid: 30708097
[17]	白桂荣, 韩晶, 梁志军, 等. 不同糖代谢人群中Txnip水平及其与炎症/氧化应激的相关性研究[J]. 宁夏医学杂志, 2021, 43(4):321-323. doi: 10.13621/j.1001-5949.2021.04.0321. doi: 10.13621/j.1001-5949.2021.04.0321
[18]	Zhao W, Pu M, Shen S, et al. Geniposide improves insulin resistance through AMPK-mediated Txnip protein degradation in 3T3-L1 adipocytes[J]. Acta Biochim Biophys Sin (Shanghai), 2021, 53(2):160-169. doi: 10.1093/abbs/gmaa157. doi: 10.1093/abbs/gmaa157
[19]	Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation[J]. Nat Immunol, 2010, 11(2):136-140. doi: 10.1038/ni.1831. doi: 10.1038/ni.1831 pmid: 20023662
[20]	Dokras A, Stener-Victorin E, Yildiz BO, et al. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome[J]. Fertil Steril, 2018, 109(5):888-899. doi: 10.1016/j.fertnstert.2018.01.038. doi: S0015-0282(18)30064-5 pmid: 29778388
[21]	Pan SM, Pan Y, Tang YL, et al. Thioredoxin interacting protein drives astrocytic glucose hypometabolism in corticosterone-induced depressive state[J]. J Neurochem, 2022, 161(1):84-100. doi: 10.1111/jnc.15489. doi: 10.1111/jnc.15489
[22]	Zhou H, Tan H, Bharti V, et al. 327-Thioredoxin-interacting protein, a potential pharmacological target for the treatment of depression[J]. Free Radic Biol Med, 2018, 128(Suppl 1):S135. doi: 10.1016/j.freeradbiomed.2018.10.357. doi: 10.1016/j.freeradbiomed.2018.10.357
[23]	Zheng T, Yang X, Wu D, et al. Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway[J]. Br J Pharmacol, 2015, 172(13):3284-3301. doi: 10.1111/bph.13120. doi: 10.1111/bph.13120
[24]	Zheng T, Yang X, Li W, et al. Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway[J]. Oxid Med Cell Longev, 2018, 2018:8597897. doi: 10.1155/2018/8597897. doi: 10.1155/2018/8597897
[25]	Mai W, Xu Y, Xu J, et al. Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis[J]. Front Pharmacol, 2020, 11:185. doi: 10.3389/fphar.2020.00185. doi: 10.3389/fphar.2020.00185
[26]	Eraky SM, Ramadan NM, Abo El-Magd NF. Antidiabetic effects of quercetin and liraglutide combination through modulation of TXNIP/IRS-1/PI3K pathway[J]. Cell Biochem Funct, 2022, 40(1):90-102. doi: 10.1002/cbf.3678. doi: 10.1002/cbf.3678
[27]	Zhang X, Zhang JH, Chen XY, et al. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation[J]. Antioxid Redox Signal, 2015, 22(10):848-870. doi: 10.1089/ars.2014.5868. doi: 10.1089/ars.2014.5868
[28]	Liu CY, Hao YN, Yin F, et al. Geniposide accelerates proteasome degradation of Txnip to inhibit insulin secretion in pancreatic β-cells[J]. J Endocrinol Invest, 2017, 40(5):505-512. doi: 10.1007/s40618-016-0591-9. doi: 10.1007/s40618-016-0591-9 pmid: 28000177
[29]	Li M, Zhang Y, Cao Y, et al. Icariin Ameliorates Palmitate-Induced Insulin Resistance Through Reducing Thioredoxin-Interacting Protein (TXNIP) and Suppressing ER Stress in C2C12 Myotubes[J]. Front Pharmacol, 2018, 9:1180. doi: 10.3389/fphar.2018.01180. doi: 10.3389/fphar.2018.01180 pmid: 30459603
[30]	Xu G, Chen J, Jing G, et al. Preventing β-cell loss and diabetes with calcium channel blockers[J]. Diabetes, 2012, 61(4):848-856. doi: 10.2337/db11-0955. doi: 10.2337/db11-0955 pmid: 22442301
[31]	Malayeri A, Zakerkish M, Ramesh F, et al. The Effect of Verapamil on TXNIP Gene Expression, GLP1R mRNA, FBS, HbA1c, and Lipid Profile in T2DM Patients Receiving Metformin and Sitagliptin[J]. Diabetes Ther, 2021, 12(10):2701-2713. doi: 10.1007/s13300-021-01145-4. doi: 10.1007/s13300-021-01145-4 pmid: 34480721
[32]	Tang G, Duan F, Li W, et al. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE^-/- mice[J]. Biomed Pharmacother, 2019, 119:109410. doi: 10.1016/j.biopha.2019.109410. doi: 10.1016/j.biopha.2019.109410
[33]	Scrimieri R, Cazzaniga A, Castiglioni S, et al. Vitamin D Prevents High Glucose-Induced Lipid Droplets Accumulation in Cultured Endothelial Cells: The Role of Thioredoxin Interacting Protein[J]. Biomedicines, 2021, 9(12):1874. doi: 10.3390/biomedicines9121874. doi: 10.3390/biomedicines9121874
[34]	Luo X, Hu Y, He S, et al. Dulaglutide inhibits high glucose- induced endothelial dysfunction and NLRP3 inflammasome activation[J]. Arch Biochem Biophys, 2019, 671:203-209. doi: 10.1016/j.abb.2019.07.008. doi: S0003-9861(19)30264-4 pmid: 31302140
[35]	Han Y, Xu X, Tang C, et al. Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis[J]. Redox Biol, 2018, 16:32-46. doi: 10.1016/j.redox.2018.02.013. doi: S2213-2317(17)30978-3 pmid: 29475133
[36]	Thielen LA, Chen J, Jing G, et al. Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action[J]. Cell Metab, 2020, 32(3):353-365.e8. doi: 10.1016/j.cmet.2020.07.002. doi: S1550-4131(20)30360-0 pmid: 32726606
[37]	Qin K, Zhang N, Zhang Z, et al. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice[J]. Diabetologia, 2018, 61(4):906-918. doi: 10.1007/s00125-017-4542-6. doi: 10.1007/s00125-017-4542-6 pmid: 29322219
[38]	Li Y, Yao N, Gao Y, et al. MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O1[J]. Bioengineered, 2021, 12(1):8555-8569. doi: 10.1080/21655979.2021.1987125. doi: 10.1080/21655979.2021.1987125

	药物名称	研究对象	主要机制
中药提取物	红景天苷	T2DM小鼠^[23]；HFD诱导的NASH小鼠^[24]	通过TXNIP/NLRP3炎症小体通路减轻氧化应激；减少肝脏中的脂质堆积
机制	黄连素	MCD诱导的NASH小鼠^[25]	同上
	槲皮素	STZ诱导的DM大鼠^[26]；HFD诱导的NASH大鼠^[27]	同上
	京尼平苷	脂肪细胞^[18]；胰岛细胞瘤细胞^[28]	增强葡萄糖摄取，增加IRS-1和GLUT-1的蛋白质水平；通过蛋白酶体途径加速TXNIP降解，改善胰岛素信号传导缺陷
	Icariin	高糖诱导的C2C12肌管细胞^[29]	通过蛋白酶体依赖性机制改善IR；抑制内质网应激
西药	维拉帕米	STZ诱导的DM小鼠^[30]；T2DM患者^[31]	减少细胞内钙，抑制钙调磷酸酶信号传导；减少ChREBP与TXNIP启动子中E-box重复序列的结合
	二甲双胍	APOE^-/-小鼠^[32]	激活AMPK，调控TRX/TXNIP复合物；抑制NLRP3炎症小体的激活
	维生素D	高葡萄糖培养的人内皮细胞^[33]	阻碍HUVECs中的脂滴形成，纠正HUVEC中的脂质代谢失衡
	度拉鲁肽	内皮细胞^[34]	抑制ROS的产生，降低NLRP3炎症小体和caspase-1的表达

	药物名称	研究对象	主要机制
中药提取物	红景天苷	T2DM小鼠^[23]；HFD诱导的NASH小鼠^[24]	通过TXNIP/NLRP3炎症小体通路减轻氧化应激；减少肝脏中的脂质堆积
机制	黄连素	MCD诱导的NASH小鼠^[25]	同上
	槲皮素	STZ诱导的DM大鼠^[26]；HFD诱导的NASH大鼠^[27]	同上
	京尼平苷	脂肪细胞^[18]；胰岛细胞瘤细胞^[28]	增强葡萄糖摄取，增加IRS-1和GLUT-1的蛋白质水平；通过蛋白酶体途径加速TXNIP降解，改善胰岛素信号传导缺陷
	Icariin	高糖诱导的C2C12肌管细胞^[29]	通过蛋白酶体依赖性机制改善IR；抑制内质网应激
西药	维拉帕米	STZ诱导的DM小鼠^[30]；T2DM患者^[31]	减少细胞内钙，抑制钙调磷酸酶信号传导；减少ChREBP与TXNIP启动子中E-box重复序列的结合
	二甲双胍	APOE^-/-小鼠^[32]	激活AMPK，调控TRX/TXNIP复合物；抑制NLRP3炎症小体的激活
	维生素D	高葡萄糖培养的人内皮细胞^[33]	阻碍HUVECs中的脂滴形成，纠正HUVEC中的脂质代谢失衡
	度拉鲁肽	内皮细胞^[34]	抑制ROS的产生，降低NLRP3炎症小体和caspase-1的表达